Skip to main content
. 2015 Jun 10;81(4):394–401. doi: 10.1016/j.bjorl.2014.09.009

Table 3.

Univariate and multivariate analysis of the relationship between the variables included in the clinical decision rule and the frequency of pharyngocutaneous fistula.

Variables All
n (%)
With fistula
n (%)
Without fistula
n (%)
Univariate analysis
p-Value
Multivariate analysis
p-Value
ASA
 2 107 (63) 25 (51.1) 82 (68) 0.05a 0.005
 3 62 (36.2) 23 (48.9) 39 (32)
Alcohol
 Heavy 126 (73.7) 38 (79.2) 88 (71.5) 0.34a 0.361
Hemoglobin pre
 <12.4 g/dL 65 (39.6) 22 (48.9) 43 (36.1) 0.15a 0.665
Albumin pre
 <37.0 g/L 30 (34.1) 7 (25) 23 (38.3) 0.24a 0.07
Co morbidities
 DM 25 (14.6) 8 (16.7) 17 (13.8) 0.63a 0.72
 COPD 18 (10.5) 3 (6.2) 15 (12.2) 0.4a
 Liver disease 39 (22.8) 11 (22.9) 28 (22.8) 1a
 Cardiopathy 42 (24.6) 11 (22.9) 31 (25.2) 0.85a
N
 N0 83 (48.6) 21 (43.8) 62 (50.4) 0.25b 0.933
 N1 25 (14.6) 8 (16.7) 17 (13.8)
 N2a + N2b + N2c 58 (33.9) 17 (9.94) 41 (23.96)
 N3 5 (2.9) 2 (1.16) 3 (1.74)
Location
 Larynx 67 (39.2) 18 (10.5) 49 (28.6) 0.86a 0.539
 Pharyngolaryngeal 104 (60.8) 30 (62.5) 74 (60.2)
Rt pre
 Yes 12 (7.0) 4 (8.3) 8 (6.5) 0.74a
CRT pre
 Yes 15 (8.8) 9 (18.8) 6 (4.9) 0.01a 0.120
Tracheotomy pre
 Yes 77 (45) 28 (58.3) 49 (39.8) 0.04a 0.144

Rt, radiotherapy; CRT, chemoradiotherapy; pre, preoperative; DM, diabetes mellitus; COPD, chronic obstructive pulmonary diseases.

a

Fisher's exact test.

b

Chi-squared test.